NCT03834727View on ClinicalTrials.gov

Characterizing the Impact and Treatment of Reproductive Tract Bleeding on Women and Post-menarchal Girls With Bleeding Disorders

CompletedOBSERVATIONAL
Enrollment

256

Participants

Timeline

Start Date

September 5, 2018

Primary Completion Date

April 1, 2022

Study Completion Date

April 1, 2022

Conditions
Hemophilia ABleeding Disorder
Trial Locations (1)

97239

Oregon Health and Science University, Portland

All Listed Sponsors
collaborator

American Thrombosis and Hemostasis Network

NETWORK

lead

Oregon Health and Science University

OTHER

NCT03834727 - Characterizing the Impact and Treatment of Reproductive Tract Bleeding on Women and Post-menarchal Girls With Bleeding Disorders | Biotech Hunter | Biotech Hunter